Open AccessS3200 ABP 710, a Biosimilar to Infliximab Reference Product: Supporting Extrapolation of Indications With a Focus on Crohn’s Disease
Author(s) -
Walter Reinisch,
Smita Halder,
Waliul I. Khan,
Xuanyu Wang,
Scott Kuhns
Publication year - 2020
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000714848.73122.58
Subject(s) - medicine , antibody dependent cell mediated cytotoxicity , infliximab , immunology , peripheral blood mononuclear cell , tumor necrosis factor alpha , immune system , pharmacology , antibody , monoclonal antibody , biology , in vitro , biochemistry